Public assets attach only after source validation.
Good AI PracticeAI use-case canvas
Future asset for Good AI Practice; publish only after source check, date check, boundary review, and revision note.
context-of-use worksheet
Future asset for Good AI Practice; publish only after source check, date check, boundary review, and revision note.
data provenance checklist
Future asset for Good AI Practice; publish only after source check, date check, boundary review, and revision note.
model card
Future asset for Good AI Practice; publish only after source check, date check, boundary review, and revision note.
human review boundary statement
Future asset for Good AI Practice; publish only after source check, date check, boundary review, and revision note.
Updates must show what changed.
revision protocolSource revision
Record date, source URL, affected pages, and what interpretation changed.
Weekly signal
Only promote signals that alter operating decisions, evidence expectations, market movement, or governance work.
Checklist release
Each checklist needs version, source links, evidence fields, public-safe disclaimer, and review boundary.
Retirement
Outdated pages should be marked, archived, or redirected without deleting the trace.
Current public sources for Good AI Practice.
official firstThese links are the public source anchors for this workspace. Interpretation, checklists, and future assets should point back here before being reused outside iFeed.
FDA guiding principles for Good AI Practice in drug development
2026-01-14 · FDA page for common Good AI Practice principles in drug development.
EMA and FDA common AI principles news
2026-01-14 · EU-facing publication context for the common principles.
EMA/HMA AI in medicinal product lifecycle
2024-09-30 · Broader medicinal-product lifecycle reflection layer for AI use and governance.
FDA/Health Canada/MHRA GMLP principles
2021-10-27 · Ten guiding principles for Good Machine Learning Practice for medical device development.